Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.

ASCO GU 2018: Renal Cell Carcinoma News Program

This year the ASCO Genitourinary Cancers Symposium took place in San Francisco from February 8th - 10th. In this Renal Cell Carcinoma News Program, we focus on the highlights for RCC at this congress.

Moderator Catherine Hood and a panel of international experts discuss the following topics:

  • Adjuvant systemic therapy
  • Cabozantinib in the first line treatment of metastatic RCC
  • The NIVOREN trial that investigates nivolumab in a ‘real world setting’
  • Combination treatments with VEGF and PD1/PD-L1 inhibition
  • Advances in treatment for papillary RCC


  • Prof. Joaquim Bellmunt, MD, medical oncologist, Dana-Farber/Brigham and Women's Cancer Center, Boston
  • Daniel George, MD, medical oncologist, Duke Cancer Center, Durham
  • Jeanny Aragon-Ching, MD, medical oncologist, Inova Fairfax hospital, Fairfax
  • Sumanta Pal, MD, medical oncologist, City of Hope Comprehensive Cancer Center, Duarte

Moderator: Catherine Hood

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items